Commentary on prevention a possible drug-drug interaction: Is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity?

Background: Drug-drug interactions (DDIs) are an emerging threat to public health and are difficult to detect. To prevent DDIs and their burden, the possible DDIs should be kept in mind. We know that the obesity predisposes to the development of insulin resistance and type 2 diabetes. Therefore, com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marjan Emzhik, Parvaneh Rahimi-Moghaddam, Soltan Ahmad Ebrahimi, Fariborz Keyhanfar, Ashraf Sadat Moazzam
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2015-01-01
Colecção:International Journal of Preventive Medicine
Assuntos:
Drug-drug interaction
human hepatocellular carcinoma cells
liver toxicity
orlistat
pioglitazone
Acesso em linha:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2015;volume=6;issue=1;spage=16;epage=16;aulast=Emzhik
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados